Liver cancer is a malignant tumor characterized by the development of one or more cancers lesions. MRI of the liver allows you to better visualize the tumor and determine the possible presence of other liver lesions.
A blood test for alpha-feto protein is also performed. The scan of the chest and abdomen allows to perform an extended assessment and to determine the presence of metastases in the lungs or bones. These nodules develop in the affected liver due to a chronic disease of fatty overload ("steatosis") or fibrotic lesions ("cirrhosis").
These lesions in the liver can occur due to excessive consumption of alcohol, steatosis, chronic viral hepatitis (B or C.). Liver cancer develops over time without causing clinical signs, making early diagnosis difficult.
“Hepatocellular carcinoma,” or “hepatocarcinomatous,” is the most common form of primary liver cancer (90% of all cases of primary liver cancer).
Cancer can occur in the bile ducts inside the liver, which is called "intrahepatic bile duct cancer" or "cholangiocarcinoma".
For hepatocellular carcinomas, if the tumor is small and localized, a partial liver resection is performed. Tumor destruction by radio frequency or radio embolization is an alternative to surgery and is performed by an interventional radiologist.
If the tumor is large or scattered in several places in the liver (diffuse), you can consider the complete removal, followed by transplantation.
If surgery is not possible and the tumor grows on a part of the liver, then chemo-embolization is performed, which helps to slow the progression of the tumor and thereby prolongs the patient's life. If the tumor is localized, stereotactic radiosurgery can also be offered in a total dose of 45 to 50 Gy in 3-5 sessions.